Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
|Videos|November 30, 2015
Trends Developing in Specialty Pharmacy
Author(s)Davy James, Managing Editor
David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses developments affecting the specialty landscape.
Advertisement
David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses developments affecting the specialty landscape.
This interview was filmed in May 2015 courtesy of Armada Health Care at the 2015 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.
Advertisement
Related to this article
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients with CKD
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
2
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
3
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
4
CagriSema Tied to 25% Weight Loss in Women, Post Hoc Data Show
5